Crystal deal tombstone commemorating a private placement by Aytu Bioscience. The commercial-stage pharmaceutical company is based in Englewood, Colorado. (9AMF327)

Crystal deal toy marking a private placement by Colorado-based pharmaceutical firm Aytu Bioscience. (9AMF327)

DNA-themed Lucite tombstone marking the acquisition of a majority stake in Spanish biotech firm Igenomix. (9LSS177)

Lucite deal toy celebrating the acquisition by Swedish fund EQT of Igenomix, a medical testing laboratory specializing in reproductive genetic services. (9LSS177)

Lucite deal tombstone marking the sale of Igenomix by European private equity fund Charme Capital Partners. Headquartered in Valencia, Spain, Igenomix is a biotechnology company focused on women's health and reproductive genetics. (9LSS177)

Custom Lucite commemorating the acquisition of Igenomix, a Spanish provider of genetic testing services for reproductive health patients. (9LSS177)

Custom crystal tombstone marking a private placement by Rezolute, a California-based clinical stage biopharmaceutical firm. (9ALJ067)

Logo-themed crystal tombstone commemorating a private placement by NovaBay Pharmaceuticals. The biopharmaceutical company is based Emeryville, California. (9AMF250)

Custom Lucite tombstone commemorating Series B funding for D&D Pharmatech. The firm develops therapeutics for dementia, Alzheimer's disease, and Parkinson's disease. (9AJH103)

Custom Lucite deal toy commemorating Series B funding for Pharmatech, the developer of a drug therapy for dementia. (9AJH103)

Side view of custom crystal tombstone recognizing a follow-on offering of common stock by Gritstone, a California-based biotech firm. (9ALJ202)

Crystal deal toy commemorating a follow-on offering by Gritstone Oncology, a clinical-stage biotechnology firm focused on cancer immunotherapies. Goldman Sachs and Cowen and Company acted as joint book-running managers for the offering. (9ALJ202)

Custom crystal marking financing provided by TPG Sixth Street Partners for a clinical study focused on ovarian cancer. (9ALJ233)

Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology.  The clinical trial sponsored by Clovis involves an ovarian cancer study. (9ALJ233)

Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis. (9AMF149)

Custom deal tombstone recognizing the acquisition of Ultimate Labs by Colorado-based Infinity Laboratories, a chemical and microbiological contract laboratory. (9ALJ145)

Custom Lucite deal toy commemorating the acquisition of San Diego-based Ultimate Labs, a testing laboratory for the pharmaceutical, biotechnology, medical device, and food industries. (9ALJ145)

Custom crystal award featuring a 3-D etch of a DNA strand. (9ACJ007)

Custom Lucite deal toy marking equity financing for DisperSol Technologies, a Texas-based drug development firm. (9ACJ018)

Custom Lucite tombstone commemorating equity financing for Georgetown, Texas-based biotech firm DisperSol Technologies. (9ACJ018)

Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer. (8ALJ479)

Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent. (8AMF064)

Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders. (8ALJ498)

Custom crystal deal toy commemorating a follow-on offering by EnteroMedics. Ladenburg Thalmann acted as sole bookrunning manager for the follow-on issue by the medical device developer. Based in St. Paul, Minnesota, the company was renamed ReShape Lifesciences in October 2017. (7AMF287)

Crystal deal toy marking a follow-on offering by InVivo Therapeutics. Headquartered in Cambridge, Massachusetts, the biotech firm specializes in the treatment of spinal cord injuries. Ladenburg Thalmann acted as sole bookrunner manager on the offering. (8AMF234)

Crystal tombstone marking the completion of Series E financing for  Epic Sciences. Funding for the San Diego-based biotech and diagnostics firm was led by Blue Ox Healthcare Partners, a private equity firm based in New York. (8ALJ481)

Plasma-themed crystal deal toy marking two transactions involving German blood plasma firm Biotest. (8LKC019)

Crystal deal toy marking a follow-on stock offering by Cellectar Biosciences. Based in Madison, Wisconsin, the firm develops cancer drugs and imaging tools. (8AMF311)

Pyramid-shaped crystal deal toy, featuring a 3-D etched logo, marking the issue of warrants by GNI Group. GNI is a Japanese biotech firm. (7ASK1110)

Diamond-shaped crystal tombstone marking the acquisition of CMC Biologics, a Danish biopharmaceutical contract manufacturer. (7ALJ205)